Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

EONS Poster Display session

CN20 - Impact of the free information service My Cancer Navigator according to patients and their relatives: An online survey

Date

15 Sep 2024

Session

EONS Poster Display session

Topics

Patient Education and Advocacy;  Communication Skills;  Multi-Disciplinary and Multi-Professional Cancer Care;  Psycho-Oncology;  Therapy;  Survivorship

Tumour Site

Presenters

Gabry Kuijten

Citation

Annals of Oncology (2024) 35 (suppl_2): S1174-S1178. 10.1016/annonc/annonc1581

Authors

G. Kuijten1, J. Hermans2, L. Vandeborne1, K. Rombauts1, G. Buyens1, M. Bollue3, P. Deroost3, R. Janssens2, I. Huys2

Author affiliations

  • 1 Patient Information, Anticancer Fund, 1860 - Meise/BE
  • 2 Clinical Pharmacology And Pharmacotherapy, KU Leuven, 3000 - Leuven/BE
  • 3 Research And Co-creation, Optigage, 1000 - Brussels/BE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract CN20

Background

My Cancer Navigator (MCN) service is the personalised information service of the Anticancer Fund. A team of scientists and physicians answers therapy-related questions of cancer patients and their relatives in an evidence-based manner. Communication occurs through email and (video)calls. The service aims to address information needs and contribute to well-informed and shared decision-making (SDM). A descriptive cross-sectional study was conducted to assess the perceived impact of MCN on users’ emotions, knowledge level and communication with healthcare professionals (HCP); all factors contributing to SDM.

Methods

Quantitative and qualitative survey questions were based on a structured literature review. After Ethics approval (Catholic University Leuven ref S67258), the survey was disseminated via e-mail to people who used MCN from April 2022 to March 2023.

Results

Of 253 invited MCN users, 109 (43.1%) filled out the survey. Respondents were 64.2% patients and 35.8% relatives. Regarding impact on emotions of anxiety, worry, stress, uncertainty, sadness, self-confidence, optimism and hope, 72.5% of MCN users reported a positive change overall; 16.5% reported no and 11.0% a negative change. Of all patients, 68.5% indicated an increased ability to cope with their disease after MCN while 76.4% of relatives indicated an increased ability to support the patient. Knowledge level of various topics (diagnostics, treatments, trials…) improved for 86.3% of MCN users, with no change for 13.7%. Regarding impact on communication with HCPs, 37.8% reported a positive change. 48.5% of patients said discussing treatments with HCPs got easier; 44% found joint decision-making easier.

Conclusions

This study highlights that a personalised information service can improve users’ emotions, knowledge level and their communication with HCPs. Hence, addressing information needs can contribute to SDM. Further research should explore how this type of service can be integrated in the care pathway.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.